Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG IL-2 plus Zidovudine or Didanosine in HIV
NCT00001997Phase 2Completed
- Sponsor
- Chiron Corporation
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of PEG-interleukin-2 in human immunodeficiency virus infection (HIV), sponsored by Chiron Corporation. Status: completed.
02
Drugs
PEG-interleukin-2
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00001997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001997.